Your browser doesn't support javascript.
loading
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
Gong, Jun; Mita, Alain C; Wei, Zihan; Cheng, Heather H; Mitchell, Edith P; Wright, John J; Ivy, S Percy; Wang, Victoria; Gray, Robert C; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Alva, Ajjai S; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T.
Afiliação
  • Gong J; Cedars-Sinai Medical Center, Los Angeles, CA.
  • Mita AC; Cedars-Sinai Medical Center, Los Angeles, CA.
  • Wei Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.
  • Cheng HH; University of Washington, Seattle, WA.
  • Mitchell EP; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA.
  • Wright JJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.
  • Gray RC; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.
  • McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Patton DR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Williams PM; Frederick National Laboratory for Cancer Research, Bethesda, MD.
  • Hamilton SR; City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Alva AS; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.
  • Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.
  • Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
JCO Precis Oncol ; 8: e2300406, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38603651
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Quinoxalinas / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Quinoxalinas / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article